Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase EARLY_PHASE1 × Completed × COVID-19 × Clear all

Phase

Phase NA 20 Phase 2 5 Phase 1 4 Phase 3 3 Phase EARLY_PHASE1 1 Phase 2/3 1 Phase 1/2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 77 Prostatic Neoplasms 35 Neoplasms 34 Glioblastoma 20 Brain Neoplasms 19 Head and Neck Neoplasms 18 Melanoma 16 Ovarian Neoplasms 15 Carcinoma, Hepatocellular 15 Squamous Cell Carcinoma of Head and Neck 14 Carcinoma, Renal Cell 14 Lung Neoplasms 13 Leukemia, Myeloid, Acute 13 Colorectal Neoplasms 13 Pancreatic Neoplasms 12 Glioma 11 Carcinoma, Non-Small-Cell Lung 10 Precursor Cell Lymphoblastic Leukemia-Lymphoma 9 Polycystic Ovary Syndrome 9 Lymphoma 9 Urinary Bladder Neoplasms 8 Myelodysplastic Syndromes 8 Multiple Myeloma 8 Endometrial Neoplasms 8 Uterine Cervical Neoplasms 7 Lymphoma, Mantle-Cell 7 Lymphoma, Large B-Cell, Diffuse 7 Triple Negative Breast Neoplasms 6 Neoplasms, Plasma Cell 6 Neoplasm Metastasis 6

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04936997 2022-05-20

Immune Response to the COVID-19 Vaccine

University of Arizona

Phase EARLY_PHASE1 Completed

COVID-19, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡